HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia

Blood

Volumn 93, Issue 11, 1999, Pages 3863-3865

  Posthuma, E F M ^a   Falkenburg, J H F ^b   Apperley, J F ^b   Gratwohl, A ^b   Roosnek, E ^b   Hertenstein, B ^b   Schipper, R F ^b   Schreuder, G M T ^b   D'Amaro, J ^b   Oudshoorn, M ^b   Biezen, J H V ^b   Hermans, J ^b   Willemze, R ^b   Niederwieser, D ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; CHIMERA; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; CYTOTOXICITY, IMMUNOLOGIC; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA-A3 ANTIGEN; HLA-B8 ANTIGEN; HUMANS; LEUKEMIA, MYELOID, CHRONIC; RISK FACTORS; T-LYMPHOCYTES;

EID: 0033152343     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Tiwari JL, Terasaki PI: HLA and disease associations: Malignancy. New York, NY, Springer Verlag, 1985, p 295
2. Caruso C, Lo Campo P, Botindari C, Modica MA: HLA antigens in Sicilian patients affected by chronic myelogenous leukemia. J Immunogenet 14:295, 1987
3. Momigliano Richiardi P, Tosi R, Martinelli G, Saglio G, Conte R, Barbanti: The HLA class I-CML association revisited taking into account the two forms of gene fusion in the Philadelphia chromosome. A multicenter study. Leukemia 8:2134, 1994
4. Bortin MM, D' Amaro J, Bach FH, Rimm AA, van Rood JJ: HLA associations with leukemia. Blood 70:227, 1987
5. D'Amaro J, Bach FH, van Rood JJ, Rimm AA, Bortin MM: HLA-C associations with acute leukemia. Lancet 2:1176, 1984
6. Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1497, 1960
7. Rowley JD: A new consistent abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290, 1973
8. Shtivelman E, Lifshitz B, Gale RP, Canaani E: Fused transcripts of abl and bcr genes in chronic myelogeous leukemia. Nature 315:550, 1985
9. Kurzock R, Gutterman JU, Talpaz M: The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 319:990, 1988
10. Bocchia M, Wentworth PA, Southwood S, Sidney J, McGraw K, Scheinberg DA, Sette A: Specific binding of leukemia oncogene fusion protein peptides to HLA class 1 molecules. Blood 85:2680, 1995
11. Dermime S, Molldrem J, Parker KC, Jiang YZ, Mavoudis D, Hensel N, Couriel D, Mahoney M, Coligan JE, Barrett AJ: Blood 86:158a, 1995 (abstr)
12. Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang SY, Sette A, Scheinberg DA: Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood 87:3587, 1996
13. Schipper RF, Schreuder GMT, D'Amaro J, Oudshoorn M: HLA gene and haplotype frequencies in Dutch blood donors. Tissue Antigens 48:562, 1996
14. Schipper RF, D'Amaro J, Bakker J, Rood JJv, Oudshoorn M: HLA gene and haplotype frequencies in Bone Marrow Donors Worldwide registries. Hum Immunol 52:54, 1997
15. BMDW Editorial board: Bone Marrow Donors Worldwide (ed 22). Leiden, The Netherlands, Europdonor Foundation, 1995
16. Woolf B: On estimating the relation between blood group and disease. Ann Hum Genet 20:251, 1995
17. Haldane JBS: The estimation and significance of the logarithm of a ratio of fequencies. Ann Hum Genet 19:309, 1955
18. Greenland S: Quantative methods in the review of epidemiologic literature. Epidemiol Rev 9:1, 1987
19. Greco G, Fruci D, Accapezzato D, Barnaba V, Nisini R, Alimena G, Montefusco E, Vigneti E, Butler R, Tanigaki N, Tosi R: Two bcr-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes. Leukemia 10:693, 1996
20. Dorak MT, Chalmers EA, Gaffney D, Wilson DWL, Galbraith I, Henderson N, Worwood M, Mills KI, Burnett AK: Human major histocompatibility complex contains several leukemia susceptibilty genes. Leuk Lymphoma 12:211, 1994
21. Hester JP, Rossen R, Trujillo J, McCredie KB, Freireich EJ: Frequency of HLA antigens in chronic myelocytic leukemia. South Med J 70:691, 1977
22. Pollack MS, DuBois D: Possible effects of non-HLA antibodies in common typing sera on HLA antigen frequency data in leukemia. Cancer 39:2348, 1977
23. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study, in Mulvihill JJ, Miller RW, Fraumeni JF (eds): Genetics of Human Cancer. New York, NY, Raven, 1977, p 321